Japan's Pharma Industry Hosts $294 Million in Tablet-Manufacturing Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking about 15 capital-spending tablet-production projects in Japan's Pharmaceutical & Biotech Industry, totaling nearly US$300 million in investment value.

Projects include the expansion of Boehringer Ingelheim Seiyaku Company Limited's (Yamagata, Japan) diabetes tablet plant in Higashine. Construction is set to begin in the fourth quarter of 2024 and is expected to wrap up in 2026. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharma & Biotech Project Database can learn more from a detailed project report and plant profile.

Subscribers can click here for a full list of project reports for tablet-production projects in Japan, and click here for a list of related plant profiles.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).